BCL6B, BCL6B transcription repressor, 255877

N. diseases: 16; N. variants: 1
Disease: Malignant Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.040 Biomarker group BEFREE B‑cell CLL/lymphoma 6 member B (BCL6B), a BCL6‑homologous gene, has been reported to be a tumor suppressor that is silenced in a variety of human cancers, including colorectal cancer (CRC). 29393377 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.040 PosttranslationalModification group BEFREE The methylation of B-cell CLL/lymphoma 6 member B (BCL6B) DNA promoter was detected in several malignancies. 25008234 2014
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.040 Biomarker group BEFREE B cell CLL/lymphoma 6 member B (BCL6B) is a novel tumor suppressor silenced in human cancer. 25218345 2014
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.040 PosttranslationalModification group BEFREE Using genome-wide promoter methylation assay, B cell CLL/lymphoma 6 member B (BCL6B) was found to be preferentially methylated in cancer. 21917650 2012